BEHANDLUNG EINES ONKOGENBEDINGTEN KREBSES MIT EINER KRAS- ODER EGFR-MUTATION DURCH VERRINGERUNG DER ADENOSINPRODUKTION ODER ANTAGONISIERUNG DER ADENOSINAKTIVIERUNG
European patent · EP3937964 · In force
Register entry
- Publication number
- EP3937964
- Application number
- EP20770898
- Kind
- European patent with effect for Switzerland and Liechtenstein
- Status
- In force
- Specification
- Granted
- Filed
- Mar 11, 2020
- Published
- Jan 19, 2022
- Granted
- Mar 11, 2026
- Protection ends at the latest
- Mar 10, 2040
- Next annual fee due
- Mar 31, 2027
- IPC classes
- A61K 38/00 (2006.01)A61K 39/00 (2006.01)A61K 39/39 (2006.01)A61P 35/00 (2006.01)A61K 31/506 (2006.01)A61K 31/519 (2006.01)A61K 31/555 (2006.01)A61K 31/675 (2006.01)A61K 31/704 (2006.01)A61K 31/7076 (2006.01)A61K 33/24 (2019.01)A61K 45/06 (2006.01)C07K 16/28 (2006.01)G01N 33/50 (2006.01)
- Priority
- US 201962817425 P 12.03.2019
- PCT application
- PCT/US2020/022028 11.03.2020
- PCT publication
- WO2020/185859 17.09.2020
- Filing language
- English
- Source
- Swissreg
History
What the Federal Institute of Intellectual Property published about this title, newest first.
- May 27, 2026
Change
Published in Swissreg on 27.05.2026
- May 27, 2026
Agent entered
- Representative
- E. Blum & Co. AG, Hofwiesenstrasse 349, 8050 Zürich
Published in Swissreg on 27.05.2026
- Mar 11, 2026
Granted
- Specification status
- Non-published patent application → Granted patent
- Status of protective title
- Initiated → Active
Published in Swissreg on 11.03.2026
Parties
Inventor
TAN, Joanne B.L.
San Francisco, California 94110, US
UDYAVAR, Akshata R.
Foster City, California 94404, US
YOUNG, Steve W.
Palomar Park, California 94062, US
The register names each party by name and address. A holder or agent is linked to an organization where exactly one entity of the commercial register bears its name; the street of a party not so recognised is not shown here.